BRIEF published on 08/16/2024 at 06:35, 3 months 5 days ago VZ Group records solid growth in the first half of 2024 Financial Services Growth Forecasts Income Benefit
PRESS RELEASE published on 08/16/2024 at 06:30, 3 months 5 days ago VZ Holding AG: VZ Group’s results grew well in the first half of the year VZ Group's first-half results show revenue growth of 12.8% to 252.9 million Swiss francs and a 19.1% increase in net profit, CEO expects continued growth throughout 2024 Revenue Growth Financial Services Switzerland Net Profit Increase VZ Group
BRIEF published on 04/08/2024 at 18:00, 7 months 12 days ago VZ Holding AG Shareholders Support Board's Proposals Unanimously Annual General Meeting Financial Statements VZ Holding AG Board Elections Dividend Approval
PRESS RELEASE published on 04/08/2024 at 17:55, 7 months 12 days ago VZ Holding AG: VZ shareholders approve all Board of Director’s motions VZ Holding AG's shareholders approve all motions at Annual General Meeting, elect new Board members. Chairman Matthias Reinhart confirmed for another term Board Of Directors Annual General Meeting Shareholders VZ Holding AG Matthias Reinhart
BRIEF published on 02/29/2024 at 06:30, 8 months 21 days ago VZ Holding AG announces notable growth in 2023 Dividend Net Profit VZ Holding AG Growth 2023 Exploitation Product
BRIEF published on 02/29/2024 at 06:30, 8 months 21 days ago VZ Holding AG announces above-average growth for 2023 Board Of Directors Revenue Growth Dividend VZ Holding AG Prospective 2024
PRESS RELEASE published on 02/29/2024 at 06:30, 8 months 21 days ago VZ Holding AG: Above-average growth for VZ Group VZ Group reports above-average growth, with revenues increasing by 14.8% to 463.8 million Swiss francs and profit by 23.5% to 187.0 million francs in 2023. Expansion of the Board of Directors planned Board Of Directors Revenues VZ Holding AG Above-average Growth Profit
PRESS RELEASE published on 08/16/2023 at 06:30, 1 year 3 months ago VZ Holding AG: VZ Group impresses with profit growth of 12.1 percent
PRESS RELEASE published on 06/28/2023 at 06:30, 1 year 4 months ago VZ Holding AG: Changes in VZ Group's Executive Board
PRESS RELEASE published on 04/13/2023 at 17:55, 1 year 7 months ago VZ Holding AG: VZ shareholders approve all Board of Director’s motions
Published on 11/21/2024 at 10:03, 35 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 38 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 38 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 3 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 13 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:04, 33 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 36 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 38 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 38 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 37 minutes ago Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 06:58, 3 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 53 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 53 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
